<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 18, 1995
----------------
W. R. GRACE & CO.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 1-3720 13-3461988
- --------------- ---------------- ------------------
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification No.)
incorporation)
One Town Center Road, Boca Raton, Florida 33486-1010
-----------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 407/362-2000
------------
<PAGE>
Item 5. OTHER EVENTS.
(a) On October 18, 1995, National Medical Care, Inc. ("NMC"), the
principal health care subsidiary of W. R. Grace & Co. ("Company"), announced
that it had received investigative subpoenas from the Office of Inspector
General ("OIG") of the U.S. Department of Health and Human Services. The
announcement stated that the subpoenas call for the production of extensive
documents relating to various aspects of NMC's business and that a letter
accompanying the subpoenas stated that they had been issued in conjunction with
an investigation being conducted by the OIG, the U.S. Attorney for the District
of Massachusetts, and others, concerning possible violations of federal laws
relating to health care payments and reimbursements.
There are five subpoenas, which cover the following areas: (i)
NMC's corporate management, personnel and employees, organizational
structure, financial information and internal communications; (ii) NMC's
dialysis services business, principally medical director contracts and
compensation; (iii) billings under the Medicare end-stage renal disease
program and, in particular, the effect on such billings of the Omnibus Budget
Reconciliation Act of 1993, which is described in NMC's Form 10 Registration
Statement filed with the
-2-
<PAGE>
Securities and Exchange Commission on September 25, 1995 ("Form 10"); (iv)
NMC's LifeChem laboratory business, including documents relating to testing
procedures, marketing, customers, competition and certain billing matters
referenced in the Form 10; and (v) NMC's Homecare Division and, in
particular, information concerning the Intradialytic Parenteral Nutrition
business, which is described in the Form 10, including billing practices
related to various services, equipment and supplies.
The Company and NMC have been reviewing and continue to assess the
subpoenas. NMC has stated that it believes that its activities have been
conducted in material compliance with all applicable laws and regulations and
that many of the issues apparently targeted by the subpoenas have been
previously disclosed or are the subject of ongoing litigation. One new
matter covered by the subpoenas relates to an area of the Homecare Division's
operations that NMC must investigate further before reaching any conclusions.
-3-
<PAGE>
It is too early to predict the results of the investigation or its
impact, if any, on NMC, its financial position or its results of operations.
In the event that any government agency believes that wrongdoing related to
the investigation has occurred, a civil or criminal proceeding could be
instituted, and if any such proceeding were to be instituted and the outcome
were unfavorable, NMC could be subject to fines, penalties and damages or
could become excluded from government reimbursement programs. Any such
result could have a material adverse effect on NMC, its financial position or
its results of operations.
For various reasons arising from the issuance of the subpoenas, the
completion of the previously reported spin-off of NMC is now expected to
occur in the first quarter of 1996, rather than the fourth quarter of 1995,
as previously reported.
(b) On or about October 20, 1995, two lawsuits were filed against
the Company, Mr. Costello and Dr. Constantine L. Hampers, the Chairman and
Chief Executive Officer of NMC. One suit was filed in the United States
District Court for the Southern District of New York (MURPHY V. W.R. GRACE &
CO., ET AL., Case Number 95CIV9003(JFK)).
-4-
<PAGE>
The other was filed in the United States District Court for the Southern
District of Florida, Northern Division (LAZAR V. W.R. GRACE & CO., ET AL.,
Case Number 95-8633(WJZ)). The lawsuits, purported class actions on behalf of
all persons and entities who purchased the Company's publicly traded
securities during periods leading up to NMC's October 18, 1995 announcement
(described in (a) above), generally allege that the defendants concealed
information, and issued misleading public statements and reports, concerning
the matters that are the subject of the investigations described in (a) above,
in violation of federal securities laws. The lawsuits seek unspecified
damages, attorneys' and experts' fees and costs, and such other relief as the
Court deems proper. The Company has been advised that additional lawsuits with
substantially similar allegations may have been or may be filed, but the
Company has not yet received service of process in these lawsuits.
-5-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed by the undersigned
thereunto duly authorized.
W. R. GRACE & CO.
---------------------------
(Registrant)
By s/Robert B. Lamm
--------------------------
Robert B. Lamm
Vice President and Secretary
Dated: October 27, 1995
-6-
